Skip to main content Accessibility help
×
Home

Epidemiological Surveillance of Amyotrophic Lateral Sclerosis in Saguenay Region

  • Émilie Lareau-Trudel (a1), Élizabeth Fortin (a1), Marianne Gauthier (a1), Sarah Lavoie (a1), Érika Morissette (a1) and Jean Mathieu (a1) (a2)...

Abstract:

Objectives:

The Neuromuscular Registry of Saguenay-Lac-Saint-Jean (SLSJ), Québec, Canada was established for epidemiological surveillance of neuromuscular disorders including amyotrophic lateral sclerosis (ALS). The objectives of this study are to analyze the ALS clinical characteristics of the SLSJ population and to determine the incidence rate over time by five year periods since 1985.

Methods:

The Registry was validated by a review of the medical records maintained at the CSSS de Chicoutimi, the regional university hospital and, by the estimation of the number of hospitalizations for ALS patients using the Quebec Hospital inpatient database (MED-ECHO).

Results:

A total of 109 patients were included. Overall, the clinical features of ALS observed in SLSJ population are similar to those described in the literature. We observed a significant increase in the incidence rate of ALS during the 2005-2009 period compared with the previous periods. This is due to a significant increase in the incidence rate among the ≥65 years old group, from 4.68 per 100,000 persons/year (CI 95% 2.88-6.48) during 1985-2004 period to 12.22 (CI 95% 7.43-17.02) during 2005-2009 period.

Conclusion:

Given the small size of the SLSJ population, a longer observation period will be needed to confirm a new steady state incidence of ALS in this region.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Epidemiological Surveillance of Amyotrophic Lateral Sclerosis in Saguenay Region
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Epidemiological Surveillance of Amyotrophic Lateral Sclerosis in Saguenay Region
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Epidemiological Surveillance of Amyotrophic Lateral Sclerosis in Saguenay Region
      Available formats
      ×

Copyright

Corresponding author

Neuromuscular Clinic, Carrefour de Santé de Jonquière, 2230 rue de l'Hôpital, Jonquière, Québec, G7X 7X2, Canada. Email: jmathieu50@videotron.ca

References

Hide All
1.Gunnarson, LG, Lindberg, G, Söderfelt, B, Axelson, O.The mortality of motor neuron disease in Sweden. Arch Neurol. 1990;47:42–6.
2.Neilson, S, Gunnarson, LG, Robinson, I.Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand. 1994;90:1509.
3.Neilson, S, Robinson, I, Nymoen, EH.Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci. 1994;122:148–54.
4.McGuire, V, Longstreth, WT Jr, Koepsell, TD, van Belle, G.Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996;47:5713.
5.Neilson, S, Robinson, I, Hunter, M.Longitudinal gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population. Mech Aging Dev. 1992;64:201–16.
6.Lilienfeld, DE, Chan, E, Ehland, J, et al.Rising mortality from motor neuron disease in the USA, 1962-84. Lancet. 1989;1:7102.
7.Cima, V, Logroscino, G, D'Ascenzo, C, et al.Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol. 2009;16:9204.
8.Fang, F, Valdimarsdóttir, U, Bellocco, R, et al.Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66:5159.
9.Murphy, M, Quinn, S, Young, J, Parkin, P, Taylor, B.Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:188995.
10.Noonan, CW, White, MC, Thurman, D, et al.Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998, Neurology. 2005;64:121521.
11.Seljeseth, YM, Vollset, SE, Tysnes, OB.Increasing mortality from amyotrophic lateral sclerosis in Norway. Neurology. 2000;55:12626.
12.Forbes, RB, Colville, S, Parratt, J, Swingler, RJ.The incidence of motor neuron disease in Scotland. J Neurol. 2007;254:8669.
13.Kihira, T, Yoshida, S, Kondo, T, et al.An increase in ALS incidence on the Kii Peninsula, 1960-2009: a possible link to change in drinking water source. Amyotroph Lateral Scler. 2012;13(4):347–50.
14.Pradat, P-F, Attarian, S, Camdessanché, JP, et al.La recherche sur la SLA en 2009: Compte rendu du groupe bibliographique de la coordination des centres SLA. Rev Neurol. 2010;166:683–98.
15.Brooks, BR, Miller, RG, Swash, M, Munsat, TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler other Motor Neuron disord. 2000;1(5):2939.
16.Monfared, AA, Lelorier, J.Accuracy and validity of using medical claims data to identify episodes of hospitalizations in patients with COPD. Pharmacoepidemiol Drug Saf. 2006;15(1):1929.
17.Worms, PM.The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:39.
18.Logroscino, G, Traynor, BJ, Hardiman, O, et al.Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
19.Armon, C.An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217–28.
20.de Jong, SW, Huisman, MH, Sutedja, NA, et al.Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol. 2012;176(3):2339.
21.Laberge, AM, Michaud, J, Richter, A, et al.Population history and its impact on medical genetics in Quebec. Clin Genet. 2005:68:287301.
22.Soriani, MH, Desnuelle, C.Épidémiologie de la SLA. Rev Neurol. 2009;165:627–40.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed